Skip to main content
Download PDF

Risk factors for postoperative medical morbidity and 3-month mortality in elderly patients with hip fracture following hip arthroplasty during COVID-19 pandemic

Journal of Orthopaedic Surgery and Research volume 18, Article number: 59 (2023) Cite this article

Abstract

Background

The purpose of the current study was to investigate the incidence of postoperative medical complications and 3-month mortality in patients  ≥ 70 years old with hip fracture following hip arthroplasty (HA) and independent risk factors associated with postoperative medical complications and 3-month mortality during the Coronavirus Disease 2019 (COVID-19) pandemic.

Methods

A multicenter retrospective study was conducted, patients  ≥ 70 years old with HA for hip fracture under general anesthesia were included during COVID-19 and before COVID-19 pandemic. The outcome was defined as postoperative medical complications and 3-month mortality. The baseline characteristics and risk factors were collected, multivariable logistic regression was used to identify independent risk factors for postoperative medical complications and 3-month mortality.

Results

A total of 1096 patients were included during COVID-19 pandemic and 1149 were included before COVID-19 pandemic in the study. Patients  ≥ 70 years with hip fracture for HA had longer fracture to operation duration (7.10 ± 3.52 vs. 5.31 ± 1.29, P < 0.001), and the incidence of postoperative medical complications (21.90% vs. 12.53%, P < 0.001) and 3-month mortality (5.20% vs. 3.22%, P = 0.025) was higher during COVID-2019 pandemic. Multivariate logistic regression analysis showed that dementia (OR 2.73; 95% CI 1.37–5.44; P = 0.004), chronic obstructive pulmonary disease (COPD) (OR 3.00; 95% CI 1.92–4.71; P < 0.001), longer fracture to operation duration (OR 1.24; 95% CI 1.19–1.30; P < 0.001) were associated with increased risk for postoperative medical complications. COPD (OR 2.10; 95% CI 1.05–4.17; P = 0.035), dementia (OR 3.00; 95% CI 1.11–7.94; P = 0.031), postoperative medical complications (OR 4.99; 95% CI 2.68–9.28; P < 0.001), longer fracture to operation duration (OR 1.11; 95% CI 1.04–1.19; P = 0.002) were associated with increased risk for 3-month mortality.

Conclusions

In conclusion, we found that postoperative medical morbidity and 3-month mortality in patients with hip fracture underwent HA were 21.90% and 5.20%, respectively, during the COVID-19. COPD, dementia and longer fracture to operation duration were associated with negative outcome in patients with hip fracture underwent HA during the COVID-19.

Background

Hip fracture is the common injuries among the elderly population in China [1, 2]. Patients with hip fractures are usually elderly, and have limited physical reserves, most patients have multiple medical comorbidities, which may increase the risk of postoperative complications and mortality [3,4,5,6]. Despite advances in multidisciplinary care, implants, anesthesia, antibiotic prophylaxis, and rehabilitation in recent years, the mortality after hip fracture surgery remains high [7, 8].

Although Sichuan and Chongqing were not at the center area of the COVID-19 pandemic, with the spread of COVID-19, many preventative measures have been implemented in all hospitals; the hospitals rapidly expanded the respiratory isolation unit and minimized the number of patients entering the ward [9, 10]. Non-emergency diagnostic imaging was postponed, and non-emergency elective surgery was postponed [11, 12]. On the other hand, fear of being infected with COVID-19 was also a reason for delayed admission.

Many studies showed that early surgery, appropriate orthopedic care, and early postoperative rehabilitation can improve the outcome among hip fracture patients [13,14,15,16,17], prolonged time to surgery has been associated with higher mortality and in-hospital complications in hip fracture [18, 19]. The COVID-19 pandemic has brought about major changes in the treatment of hip fracture, prolongation of time from fracture to operation, increased preoperative evaluation, and reduced postoperative rehabilitation can affect the prognosis of patients.

Due to the developing nature of the COVID-19 pandemic, the morbidity and mortality in patients hip fracture after hip arthroplasty (HA) were unclear during the COVID-19 pandemic. Therefore, in this study, we retrospectively collected data in four hospitals to investigate the effect of COVID-19 pandemic on short-term outcomes of patients  ≥ 70 years with hip fracture for HA and the incidence of postoperative medical complications and 3-month mortality and identified some independent risk factors associated with postoperative medical complications and 3-month mortality during the COVID-19 pandemic.

Methods

Patients and clinical data

We conducted a multicenter retrospective study. The study was carried out at four hospitals located in Sichuan and Chongqing: The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, The Second People’s Hospital of Chengdu, Sichuan Province Orthopedic Hospital, Chongqing Orthopedics Hospital of Traditional Chinese Medical. Chongqing Orthopedics Hospital of Traditional Chinese Medical was more than 500-bed grade IIA hospital. The Affiliated Traditional Chinese Medical Hospital of Southwest Medical University, Sichuan Province Orthopedic Hospital, and the Second People’s Hospital of Chengdu were more than 1000-bed grade III A hospital. All patients who underwent primary HA for hip fractures were included in our study during COVID-19 pandemic (between 1 January 2020 and 30 December 2020) and before COVID-19 pandemic (between 1 January 2019 and 30 December 2019). The study was approved by the ethics committee of all the study center.

Hip fracture (femoral neck fracture or intertrochanteric fracture) was captured in the registry by using International Classification of Diseases Tenth revision (ICD-10) code reading (S72.0 and S72.1), and then, all the patients were screened manually. We included patients  ≥ 70 years old if they experienced HA for hip fracture under general anesthesia. The exclusion criteria were the following: (1) receiving bilateral arthroplasty; (2) undergoing general or regional anesthesia within 3 months; (3) revision arthroplasty; (4) multiple injuries; (5) pathological fracture or ongoing chemotherapy for a tumorous condition; (6) < 70 years old; (7) COVID-19 infection. Four clinicians (RH, HS, PZ, and YL) collected information by reviewing the Electronic Medical Record (EMR) system from four hospitals.

A data extraction form was designed and used to record the patient characteristics. The data were extracted from the Electronic Medical Record (EMR) system which include demographic characteristics [included age, gender, body mass index (BMI)], [medical history, current smoking, hypertension, hypertension, diabetes, hyperlipidemia, dementia, heart disease, chronic renal disease, chronic liver disease, chronic obstructive pulmonary disease (COPD)], and preoperative factors [albumin (ALB) and hemoglobin (HGB)].

In-hospital medical complications were defined as follows: infections (pneumonia, urinary tract infection, or other infections), vascular complications (e.g., deep venous thrombosis, pulmonary embolism, myocardial infarction, stroke), and neurologic complications (e.g., sciatic palsy).

The outcome was defined as postoperative medical complications and 3-month mortality in patient with hip fracture following HA. 3-month mortality was obtained by telephone consultation or medical records.

Statistical analysis

The data are presented as numbers (%) or means (± standard deviations). Pearson χ2 tests were used for categorical variables. Student’s t tests were used to compare normally distributed variables. Mann–Whitney U tests were used to compare nonnormally distributed variables. Variables associated with postoperative medical complications and 3-month mortality in the univariate analyses with a P value < 0.20 were included in the multivariate analysis. Multivariate logistic regression analysis was performed to identify determinants independently associated with postoperative medical complications and 3-mortality. The results were expressed as the adjusted odds ratio (aOR) with their corresponding 95% confidence interval (CI). The data were analyzed using SPSS 22 software. P < 0.05 was considered statistically significant.

Results

Demographic characteristics

During the January 1, 2020 to December 30, 2020 period, a total of 1196 patients were enrolled at the four centers. Among them, 27 patients underwent hip repair, 10 patients received bilateral arthroplasty, and 53 patients with 1 or more of the other exclusion criteria were excluded, 10 patients missed information. The remaining 1096 patients were recruited in this study, there were 556 (50.73%) female and 540 (49.27%) male patients with the mean age of 76.14 ± 6.32 years (range: 70–97 years); of them, 103 (9.40%) had COPD, 352 (32.12%) patients had a history of hypertension, 41 (3.72%) patients had dementia, 301 (27.46%) had diabetes, and 533 (48.63%) had hyperlipidemia. The time from hip fracture to surgery was 7.10 ± 3.52 days.

During the January 1, 2019 to December 30, 2019 period, a total of 1264 patients were enrolled at the four centers. Among them, 30 patients underwent hip repair, 12 patients received bilateral arthroplasty, and 60 patients with 1 or more of the other exclusion criteria were excluded, 13 patients missed information. The remaining 1149 patients were recruited in this study, there were 567 (49.35%) female and 582 (50.65%) male patients with the mean age of 76.35 ± 6.40 years (range: 70–97 years); of them, 115 (10.01%) had COPD, 373 (32.46%) patients had a history of hypertension, 38 (3.31%) patients had dementia, 317 (27.59%) had diabetes, 588 (51.17%) had hyperlipidemia. The time from hip fracture to surgery was 5.31 ± 1.29 days.

Compared with patients in no COVID-19 pandemic group, patients in COVID-19 pandemic group had significantly longer fracture to operation duration (7.10 ± 3.52 vs. 5.31 ± 1.29, P < 0.001), the incidence of medical complications and 3-month mortality was higher in COVID-19 pandemic group (P < 0.005). There was no significant difference in gender, age, dementia, COPD, hypertension, current smoking, diabetes, hyperlipidemia, heart disease, chronic renal disease, chronic liver disease, ALB, RBC, operating times and the mean length of stay (LOS) (P > 0.05). Baseline characteristics of patients in the no COVID-19 pandemic group and COVID-19 pandemic group are shown in Table 1.

Table 1 Comparison of baseline characteristics between patients with no COVID-19 period and COVID-19 pandemic groups
Full size table

In COVID-19 pandemic group, 240 (21.90%) patients developed postoperative medical complications after HA. A total of 162 (14.78%) patients had infection during the hospital stay, 25 (2.28%) patients had stroke, 23 (2.10%) had deep venous thrombosis, 12 (1.09%) had myocardial infarction, 8 (0.72%) had acute kidney injury, and 10 (0.91%) had gastrointestinal bleeding. The mean LOS was 13.72 days (13.72 ± 7.51 days).

In no COVID-19 pandemic group, 144 (12.53%) patients developed postoperative medical complications after HA. A total of 104 (9.05%) patients had infection during the hospital stay, 15(1.31%) patients had stroke, 12 (1.04%) had deep venous thrombosis, 5 (0.44%) had myocardial infarction, 3 (0.26%) had acute kidney injury, and 5 (0.44%) had gastrointestinal bleeding. The mean LOS was 13.23 days (13.23 ± 6.45 days). Compared with patients with medical complications in no COVID-19 pandemic group, patients with medical complications in COVID-19 pandemic group had longer mean LOS (17.75 ± 9.00 vs. 15.23 ± 6.21, P = 0.009).

Univariable models for predictors of postoperative medical complications in COVID-19 pandemic group

Univariate analysis found that fracture to operation duration, dementia and COPD were all significantly associated with increased risk for postoperative medical complications (Table 2). Compared with patients with no medical complications, patients with medical complications had significantly longer fracture to operation duration (9.30 ± 4.41 vs. 6.60 ± 2.97, P < 0.001), the percentage of dementia [16 (6.67%) vs. 25 (2.92%), P = 0.007; OR 2.37; 95% CI 1.25–4.52; P = 0.007] and COPD [47 (19.17%) vs. 57 (6.66%), P < 0.001; OR 3.32; 95% CI 1.19–5.05; P < 0.001]. The mean LOS was 17.75 ± 9.00 days for medical complications and 12.59 ± 6.62 days for no medical complications, respectively, the difference between the two groups was about 5 days (P < 0.001).

Table 2 Comparison of baseline characteristics between patients with no complications and complications groups
Full size table

Multivariable models on the association between risk factors and postoperative medical complications in COVID-19 pandemic group

Unadjusted logistic regression analysis identified longer fracture to operation duration (OR 1.24; 95% CI 1.19–1.29; P < 0.001), higher percentage of dementia (OR 2.37; 95% CI 1.25–4.52; P = 0.009) and COPD (OR 3.32; 95% CI 2.19–5.05; P < 0.001) as risk factors associated with postoperative medical complications. When variables associated with postoperative medical complications in the univariate analyses with a P value < 0.20 were included in the multivariate analysis (adjusted for current smoking, dementia, COPD, fracture to operation duration), the results showed that dementia (OR 2.73; 95% CI 1.37–5.44; P = 0.004), COPD(OR 3.00; 95% CI 1.92–4.71; P < 0.001), longer fracture to operation duration (OR 1.24; 95% CI 1.19–1.30; P < 0.001) were associated with increased risk for postoperative medical complications (Table 3).

Table 3 Multivariable models showing factors associated with postoperative medical complications
Full size table

Univariable Models for Predictors of death in COVID-19 pandemic group

Fifty-seven out of 1096 (5.20%) patients had died at 3 months. Baseline characteristics of patients in the survivor and dead groups were compared (Table 4). At baseline, dead group showed significantly longer fracture to operation duration (9.80 ± 4.58 vs. 7.05 ± 3.40, P < 0.001), the percentage of COPD [14 (24.56%) vs. 89 (8.57%); OR 3.48; 95% CI 1.83–6.60; P < 0.001] and postoperative medical complications [37 (64.91%) vs203 (19.54%); OR 8.03; 95% CI 4.52–14.26; P < 0.001] than patients with survivor group (Table 4).

Table 4 Comparison of baseline characteristics between patients with survival and death groups
Full size table

Multivariable Models on the Association between risk factors and 3-month mortality in COVID-19 pandemic

Unadjusted logistic regression analysis identified longer fracture to operation duration (OR 1.20; 95% CI 1.12–1.28; P < 0.001), the percentage of COPD (OR 3.48; 95% CI 1.83–6.60; P < 0.001), dementia (OR 3.38; 95% CI 1.34–8.39; P < 0.001) and postoperative medical complications (OR 7.62; 95% CI 4.33–13.41; P < 0.001) as risk factors associated with 3-mortality. When variables associated with 3-mortality in the univariate analyses with a P value < 0.20 were included in the multivariate analysis (adjusted for age, dementia, COPD, fracture to operation duration and postoperative medical complications), the results showed that percentage of COPD (OR 2.10; 95% CI 1.05–4.17; P = 0.035), dementia (OR 3.00; 95% CI 1.11–7.94; P = 0.031), postoperative medical complications (OR 4.99; 95% CI 2.68–9.28; P < 0.001), longer fracture to operation duration (OR 1.11; 95% CI 1.04–1.19; P = 0.002) were associated with increased risk for 3-month mortality (Table 5).

Table 5 Multivariable models showing factors associated with 3-month mortality
Full size table

Discussion

In this study, we reported the effect of COVID-19 pandemic on short-term outcomes of patients  ≥ 70 years with hip fracture for HA and investigated incidence of postoperative medical complications and 3-month mortality and identified some independent risk factors associated with incidence of postoperative medical complications and 3-month mortality during the COVID-19 pandemic in four hospitals. Few patients were operated within 48 h of hospital admission during the COVID-19 pandemic, as envisaged by the standardized organizational model [20, 21]. In this study, we found that patients  ≥ 70 years with hip fracture for HA had longer fracture to operation duration and the incidence of postoperative medical complications and 3-month mortality was higher during COVID-19 pandemic. Several factors associated with increased the risk for postoperative medical complications and 3-month mortality.

In this study, the results showed that the most common complications were infection, including pneumonia, urinary tract infection or other infections. Patients who experienced postoperative medical complications had longer fracture to operation duration, percentage of dementia and COPD. Multivariate logistic regression analyses indicated that dementia, COPD and longer fracture to operation duration were associated with postoperative medical complications in patients  ≥ 70 years old after HA for hip fracture, and the results also showed that COPD, longer fracture to operation duration and perioperative complications were associated with the increased risk for 3-month mortality.

Dementia is a very common medical comorbidity in elderly patients with hip fracture, it is associated with an increased risk of poor postoperative outcomes, including increased mortality and morbidity [22, 23]. The reasons may be that patients with dementia have more severe medical comorbidities and have a poorer reserve for physical function. In this study, the incidence of dementia was 3.46%, which was much lower than previous studies [22,23,24]. The reason might be that this study was a retrospective study, and most of the dementia history was provided by the patients' family members and patients. However, in this study the results showed that patients with dementia experienced higher complications after THA (40%, 12/30), which was consistent with previous studies [25, 26]. Previous studies also showed that preoperative risk factors for in-hospital mortality were advanced age, presence of comorbid diseases such as dementia, and renal or cerebrovascular disease [27, 28], and patients with a diagnosis of dementia had higher in-hospital mortality (P < 0.001) [28]. The two retrospective studies included a combined total of 40,958 and showed that patients with dementia and age over 90 years old have a higher 90 day and 1-year mortality with hazards of 88% (P = 0.01) and 75% (P = 0.01), respectively [29, 30]. In this study, dementia was not associated with 3-month mortality, which may be related to the low number of dementia patients. In our study, we found that dementia was associated with the increased the risk for postoperative medical complications, and latter was associated with the increased the risk for 3-month mortality. Therefore, postoperative care processes such as rehabilitation may provide for better surveillance of postoperative complications while they are in this setting and participation in rehabilitation may help prevent complications.

During the epidemic period, all aspects of social life were affected, the government adopted a series of containment measures to limit the spread of COVID-19, including extensive testing, quarantine of cases and prohibiting gathering [31,32,33]. Patients with hip fracture were more likely to reside in residential home, which may lead to longer time from fracture to operation. Delay for hip fracture surgery is undesirable. When patients sustain a hip fracture, they are forced to lie flat in a bed and are either in pain or needing analgesic medications, which often have side effects [34, 35]. Previous study found that patients who received operation within 2 days after injury had lower in-hospital mortality and had better outcomes [30, 36, 37]. In this study, we found the mean fracture to operation duration was 7.10 days in COVID-19 pandemic group, and 5.31 days in no COVID-19 pandemic group, the difference between the two groups was about 2 days, and the incidence of postoperative medical complications and 3-month mortality was 21.90% and 5.20% for COVID-19 pandemic group compared to 12.53% and 3.22% for no COVID-19 pandemic group in patients ≥ 70 years with hip fracture following HA.

The key to advocating early surgery is to restore motor function at an early stage and to reduce complications associated with bed rest. Such complications can occur not only postoperatively but also preoperatively. A previous study showed that patients admitted one week after injury had higher incidence of preoperative pneumonia and lower level of albumin [37]. Our study also showed that longer fracture to operation duration was associated with an increased risk for postoperative medical complications. We speculate the intrinsic link is that with admission delay continuing and bedridden time prolonging, preoperative pneumonia would appear and aggravate, and nutritional status would deteriorate.

COPD has been associated with impaired bone metabolism, patients undergoing THA with underlying COPD face a higher rate of comorbidities, respiratory complications, implant complications and revision surgeries, than patients without COPD [38]. Studies have shown an increased risk of myocardial infarction, pneumonia, unplanned reintubation, deep infection and 30-day readmission rates [39,40,41,42,43,44]. Patients with COPD present an additional challenge, given decreased pulmonary reserve and associated chronic diseases, making them susceptible to further complications [45, 46]. In our studies, the results showed that patients with COPD, hip fracture and prolongation of time to surgery presented additional challenges, patients undergoing HA had an increased risk of postoperative medical complications and 3-month mortality, which consists of previous studies [45, 46].

In this study, we found that there was no significant difference in mean LOS between COVID-19 pandemic and no COVID-19 pandemic groups, but mean LOS of patients with postoperative medical complications was significantly longer than those who without postoperative medical complications, and the mean LOS of patients with medical complications during the COVID-19 pandemic was also significantly longer than those who in no COVID-19 pandemic. We speculated that the possible reason for these results was that during the COVID-19 pandemic, prolonged time to surgery might cause more serious postoperative medical complications, so longer hospitalization was needed for patients.

There were some limitations of this study. First, this is a retrospective study, history of dementia was provided by patients and families, and the incidence of dementia in patients with hip fractures may be underestimated, which may have resulted in response bias. Second, Sichuan and Chongqing are not the COVID-19 pandemic central area, the results may not be representative. Third, postoperative indicators (such as plasma albumin levels, hemoglobin levels, duration spent in intensive care unit, postoperative rehabilitation and care level) may have affected the outcomes. Fourthly, the specific operative technique, family history, physical activity and dietary habits were not capture. In addition, we lacked data on APACHE scores and the approach of the surgery. Despite the limitations mentioned above, this study was a multicenter study with a large number of patients; our results provide valuable information on morbidity and mortality in elderly patients with total hip arthroplasty for hip fracture during COVID-19 pandemic.

Conclusions

In conclusion, we found that prolongation of time to surgery was common, and postoperative medical morbidity and 3-month mortality in patients with hip fracture underwent HA were 22.29% and 5.89% during the COVID-19 pandemic, respectively, which were significantly higher than those before COVID-19 pandemic. COPD, dementia and longer fracture to operation duration were associated with negative outcome in patients with hip fracture underwent HA. In the era of COVID-19, the healthcare system must adopt new approaches (including provision of rapid COVID-19 testing, early surgery and ensuring availability of operating rooms and staff, multidisciplinary approach) to reduce mortality and medical complications in patients with hip fractures underwent HA.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

CI:

Confidence interval

M:

Mean

OR:

Odds ratio

SD:

Standard deviation

COVID-19:

Coronavirus disease 2019

HA:

Hip arthroplasty

COPD:

Chronic obstructive pulmonary disease

References

  1. Zhang C, Feng J, Wang S, Gao P, Xu L, Zhu J, Jia J, Liu L, Liu G, Wang J, Zhan S, Song C. Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study. PLoS Med. 2020;17(8):e1003180. https://doi.org/10.1371/journal.pmed.1003180.

    Article  Google Scholar 

  2. Sheikh HQ, Aqil A, Hossain FS, Kapoor H. There is no weekend effect in hip fracture surgery-a comprehensive analysis of outcomes. Surgeon. 2018;16(5):259–64. https://doi.org/10.1016/j.surge.2017.11.001.

    Article  Google Scholar 

  3. Wahlsten LR, Palm H, Gislason GH, Brorson S. Sex differences in incidence rate, and temporal changes in surgical management and adverse events after hip fracture surgery in Denmark 1997–2017: a register-based study of 153,058 hip fracture patients. Acta Orthop. 2021;14:1–7. https://doi.org/10.1080/17453674.2021.1923256.

    Article  Google Scholar 

  4. Moran CG, Wenn RT, Sikand M, Taylor AM. Early mortality after hip fracture: Is delay before surgery important? JBJS. 2005;87(3):483–9. https://doi.org/10.2106/JBJS.D.01796.

    Article  Google Scholar 

  5. Migliorini F, Giorgino R, Hildebrand F, Spiezia F, Peretti GM, Alessandri-Bonetti M, Eschweiler J, Maffulli N. Fragility fractures: risk factors and management in the elderly. Medicina. 2021;57(10):1119. https://doi.org/10.3390/medicina57101119.

    Article  Google Scholar 

  6. Mirghaderi SP, Sheikhbahaei E, Salimi M, Mirghaderi SR, Ahmadi N, Moharrami A, Motififard M, Mortazavi SMJ. COVID-19 infection rate after urgent versus elective total hip replacement among unvaccinated individuals: a multicenter prospective cohort amid the COVID-19 pandemic. Ann Med Surg. 2022;80:104307. https://doi.org/10.1016/j.amsu.2022.104307.

    Article  Google Scholar 

  7. Westberg M, Snorrason F, Frihagen F. Preoperative waiting time increased the risk of periprosthetic infection in patients with femoral neck fracture. Acta Orthop. 2013;84(2):124–9. https://doi.org/10.3109/17453674.2013.775044.

    Article  Google Scholar 

  8. Auerbach A, O'Leary KJ, Greysen SR, Harrison JD, Kripalani S, Ruhnke GW, Vasilevskis EE, Maselli J, Fang MC, Herzig SJ, Lee T; HOMERuN COVID-19 Collaborative Group. Hospital Ward adaptation during the COVID-19 pandemic: a national survey of academic medical centers. J Hosp Med. 2020; 15(8):483–488. https://doi.org/10.12788/jhm.3476

  9. Malik-Tabassum K, Crooks M, Robertson A, To C, Maling L, Selmon G. Management of hip fractures during the COVID-19 pandemic at a high-volume hip fracture unit in the United Kingdom. J Orthop. 2020;20:332–7. https://doi.org/10.1016/j.jor.2020.06.018.

    Article  Google Scholar 

  10. Earp BE, Zhang D, Benavent KA, Byrne L, Blazar PE. The Early effect of COVID-19 restrictions on an academic orthopedic surgery department. Orthopedics. 2020;43(4):228–32. https://doi.org/10.3928/01477447-20200624-03.

    Article  Google Scholar 

  11. Wu K, Smith CR, Lembcke BT, Ferreira TBD. Elective surgery during the COVID-19 pandemic. N Engl J Med. 2020;383(18):1787–90. https://doi.org/10.1056/NEJMclde2028735.

    Article  Google Scholar 

  12. Simunovic N, Devereaux PJ, Sprague S, Guyatt GH, Schemitsch E, Debeer J, Bhandari M. Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ. 2010;182(15):1609–16. https://doi.org/10.1503/cmaj.092220.

    Article  Google Scholar 

  13. Brox WT, Roberts KC, Taksali S, Wright DG, Wixted JJ, Tubb CC, Patt JC, Templeton KJ, Dickman E, Adler RA, Macaulay WB, Jackman JM, Annaswamy T, Adelman AM, Hawthorne CG, Olson SA, Mendelson DA, LeBoff MS, Camacho PA, Jevsevar D, Shea KG, Bozic KJ, Shaffer W, Cummins D, Murray JN, Donnelly P, Shores P, Woznica A, Martinez Y, Boone C, Gross L, Sevarino K. The American academy of orthopaedic surgeons evidence-based guideline on management of hip fractures in the elderly. J Bone Joint Surg Am. 2015;97(14):1196–9. https://doi.org/10.2106/JBJS.O.00229.

    Article  Google Scholar 

  14. Al-Ani AN, Samuelsson B, Tidermark J, Norling A, Ekström W, Cederholm T, Hedström M. Early operation on patients with a hip fracture improved the ability to return to independent living. A prospective study of 850 patients. J Bone Joint Surg Am. 2008;90(7):1436–42. https://doi.org/10.2106/JBJS.G.00890.

    Article  Google Scholar 

  15. Bottle A, Aylin P. Mortality associated with delay in operation after hip fracture: observational study. BMJ. 2006;332(7547):947–51. https://doi.org/10.1136/bmj.38790.468519.55.

    Article  Google Scholar 

  16. Pincus D, Ravi B, Wasserstein D, Huang A, Paterson JM, Nathens AB, Kreder HJ, Jenkinson RJ, Wodchis WP. Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA. 2017;318(20):1994–2003. https://doi.org/10.1001/jama.2017.17606.

    Article  Google Scholar 

  17. Lefaivre KA, Macadam SA, Davidson DJ, Gandhi R, Chan H, Broekhuyse HM. Length of stay, mortality, morbidity and delay to surgery in hip fractures. J Bone Joint Surg Br. 2009;91(7):922-927. https://doi.org/10.1302/0301-620X.91B7.22446

  18. Nyholm AM, Gromov K, Palm H, Brix M, Kallemose T, Troelsen A; Danish Fracture Database Collaborators. Time to surgery is associated with thirty-day and ninety-day mortality after proximal femoral fracture: a retrospective observational study on prospectively collected data from the Danish fracture database collaborators. J Bone Joint Surg Am. 2015;97(16):1333–1339. https://doi.org/10.2106/JBJS.O.00029.

  19. Blanco JF, da Casa C, Pablos-Hernández C, González-Ramírez A, Julián-Enríquez JM, Díaz-Álvarez A. 30-day mortality after hip fracture surgery: influence of postoperative factors. PLoS ONE. 2021;16(2):e0246963. https://doi.org/10.1371/journal.pone.0246963.

    Article  CAS  Google Scholar 

  20. Sheehan KJ, Sobolev B, Guy P. Mortality by timing of hip fracture surgery: factors and relationships at play. J Bone Joint Surg Am. 2017;99(20):e106. https://doi.org/10.2106/JBJS.17.00069.

    Article  Google Scholar 

  21. Seitz DP, Adunuri N, Gill SS, Rochon PA. Prevalence of dementia and cognitive impairment among older adults with hip fractures. J Am Med Dir Assoc. 2011;12(8):556–64. https://doi.org/10.1016/j.jamda.2010.12.001.

    Article  Google Scholar 

  22. HIP Attack Investigators. Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomized, controlled trial. Lancet. 2020;395(10225):698–708. https://doi.org/10.1016/S0140-6736(20)30058-1.

    Article  Google Scholar 

  23. Vidán MT, Sánchez E, Gracia Y, Marañón E, Vaquero J, Serra JA. Causes and effects of surgical delay in patients with hip fracture: a cohort study. Ann Intern Med. 2011;155(4):226–33. https://doi.org/10.7326/0003-4819-155-4-201108160-00006.

    Article  Google Scholar 

  24. Heng M, Eagen CE, Javedan H, Kodela J, Weaver MJ, Harris MB. Abnormal minicog is associated with higher risk of complications and delirium in geriatric patients with fracture. J Bone Joint Surg Am. 2016;98(9):742–50. https://doi.org/10.2106/JBJS.15.00859.

    Article  Google Scholar 

  25. Michet CJ 3rd, Schleck CD, Larson DR, Maradit Kremers H, Berry DJ, Lewallen DG. Cause-specific mortality trends following total hip and knee arthroplasty. J Arthroplasty. 2017;32(4):1292–7. https://doi.org/10.1016/j.arth.2016.10.009.

    Article  Google Scholar 

  26. Memtsoudis SG, Della Valle AG, Besculides MC, Esposito M, Koulouvaris P, Salvati EA. Risk factors for perioperative mortality after lower extremity arthroplasty: a population-based study of 6,901,324 patient discharges. J Arthroplasty. 2010;25(1):19–26. https://doi.org/10.1016/j.arth.2008.11.010.

    Article  Google Scholar 

  27. Buller LT, Best MJ, Klika AK, Barsoum WK. The influence of psychiatric comorbidity on perioperative outcomes following primary total hip and knee arthroplasty; a 17-year analysis of the National Hospital Discharge Survey database. J Arthroplast. 2015;30(2):165–70. https://doi.org/10.1016/j.arth.2014.08.034.

    Article  Google Scholar 

  28. Fansa A, Huff S, Ebraheim N. Prediction of mortality in nonagenarians following the surgical repair of hip fractures. Clin Orthop Surg. 2016;8(2):140–5. https://doi.org/10.4055/cios.2016.8.2.140.

    Article  Google Scholar 

  29. Viramontes O, Luan Erfe BM, Erfe JM, Brovman EY, Boehme J, Bader AM, Urman RD. Cognitive impairment and postoperative outcomes in patients undergoing primary total hip arthroplasty: a systematic review. J Clin Anesth. 2019;56:65–76. https://doi.org/10.1016/j.jclinane.2019.01.024.

    Article  Google Scholar 

  30. Migliorini F, Vaishya R, Eschweiler J, Oliva F, Hildebrand F, Maffulli N. Vitamins C and D and COVID-19 susceptibility, severity and progression: an evidence based systematic review. Medicina. 2022;58(7):941. https://doi.org/10.3390/medicina58070941.

    Article  Google Scholar 

  31. Migliorini F, Torsiello E, Spiezia F, Oliva F, Tingart M, Maffulli N. Association between HLA genotypes and COVID19 susceptibility, severity and progression: a comprehensive review of the literature. Eur J Med Res. 2021;26(1):84. https://doi.org/10.1186/s40001-021-00563-1.

    Article  CAS  Google Scholar 

  32. Giordano L, Cipollaro L, Migliorini F, Maffulli N. Impact of Covid-19 on undergraduate and residency training. Surgeon. 2021;19(5):e199–206. https://doi.org/10.1016/j.surge.2020.09.014.

    Article  Google Scholar 

  33. Paul P, Issac RT. Delay in time from fracture to surgery: a potential risk factor for in-hospital mortality in elderly patients with hip fractures. J Orthop. 2018;15(2):375–8. https://doi.org/10.1016/j.jor.2018.03.001.

    Article  Google Scholar 

  34. Anthon CA, Duchman KR, Bedard NA, Gholson JJ, Gao YB, Pugely AJ, Callaghan JL. Hip fractures: appropriate timing to operative intervention. J Arthroplast. 2017;32(11):3314–8. https://doi.org/10.1016/j.arth.2017.07.023.

    Article  Google Scholar 

  35. Khan SK, Kalra S, Khanna A, Thiruvengada MM, Parker MJ. Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291413 patients. Injury. 2009;40(7):692–7. https://doi.org/10.1016/j.injury.2009.01.010.

    Article  Google Scholar 

  36. He W, You YY, Sun K, Xie C, Ming Y, Yu LN, Zhang FJ, Yan M. Admission delay is associated with worse surgical outcomes for elderly hip fracture patients: a retrospective observational study. World J Emerg Med. 2020;11(1):27–32. https://doi.org/10.5847/wjem.j.1920-8642.2020.01.004.

    Article  Google Scholar 

  37. Yang DS, Glasser J, Lemme NJ, Quinn M, Daniels AH, Antoci V Jr. Increased medical and implant-related complications in total hip arthroplasty patients with underlying chronic obstructive pulmonary disease. J Arthroplasty. 2021;S0883–5403(21):00137–46. https://doi.org/10.1016/j.arth.2021.02.011.

    Article  Google Scholar 

  38. Elsamadicy AA, Sergesketter AR, Kemeny H, Adogwa O, Tarnasky A, Charalambous L, Lubkin DET, Davison MA, Cheng J, Bagley CA, Karikari IO. Impact of chronic obstructive pulmonary disease on postoperative complication rates, ambulation, and length of hospital stay after elective spinal fusion (≥3 levels) in elderly spine deformity patients. World Neurosurg. 2018;116:e1122–8. https://doi.org/10.1016/j.wneu.2018.05.185.

    Article  Google Scholar 

  39. Elsamadicy AA, Sergesketter AR, Kemeny H, Adogwa O, Tarnasky A, Charalambous L, Lubkin DET, Davison MA, Cheng J, Bagley CA, Karikari IO. Impact of COPD on postoperative outcomes: results from a national database. Chest. 2013;143(6):1599–606. https://doi.org/10.1378/chest.12-1499.

    Article  Google Scholar 

  40. Lopez Ramos C, Brandel MG, Rennert RC, Wali AR, Steinberg JA, Santiago-Dieppa DR, Burton BN, Pannell JS, Olson SE, Khalessi AA. Clinical risk factors and postoperative complications associated with unplanned hospital readmissions after cranial neurosurgery. World Neurosurg. 2018;119:e294–300. https://doi.org/10.1016/j.wneu.2018.07.136.

    Article  Google Scholar 

  41. Yakubek GA, Curtis GL, Sodhi N, Faour M, Klika AK, Mont MA, Barsoum WK, Higuera CA. Chronic obstructive pulmonary disease is associated with short-term complications following total hip arthroplasty. J Arthroplast. 2018;33(6):1926–9. https://doi.org/10.1016/j.arth.2017.12.043.

    Article  Google Scholar 

  42. Gu A, Wei C, Maybee CM, Sobrio SA, Abdel MP, Sculco PK. The impact of chronic obstructive pulmonary disease on post-operative outcomes in patients undergoing revision total knee arthroplasty. J Arthroplast. 2018;33(9):2956–60. https://doi.org/10.1016/j.arth.2018.05.009.

    Article  Google Scholar 

  43. Lee R, Lee D, Mamidi IS, Probasco WV, Heyer JH, Pandarinath R. Patients with chronic obstructive pulmonary disease are at higher risk for pneumonia, septic shock, and blood transfusions after total shoulder arthroplasty. Clin Orthop Rel Res. 2019;477(2):416–23. https://doi.org/10.1097/CORR.0000000000000531.

    Article  Google Scholar 

  44. Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091–7. https://doi.org/10.1378/chest.09-2029.

    Article  Google Scholar 

  45. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(9):1618–23. https://doi.org/10.1164/ajrccm.164.9.2105011.

    Article  CAS  Google Scholar 

  46. Lee D, Lee R, Tran A, Shah N, Heyer JH, Hughes AJ, Pandarinath R. Hemiarthroplasty versus total hip arthroplasty for femoral neck fractures in patients with chronic obstructive pulmonary disease. Eur J Trauma Emerg Surg. 2021;47(2):547–55. https://doi.org/10.1007/s00068-019-01234-x.

    Article  Google Scholar 

Download references

Acknowledgements

We thank all patients and their families for generously consenting to use of human tissues in this research.

Funding

No funding source for this work.

Author information

Author notes

  1. Huarui Shen and Rui He are co-first authors of the article.

Authors and Affiliations

  1. Department of Joint Surgery, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, 646000, China

    Huarui Shen & Guoyou Wang

  2. Department of Orthopedics, The Second People’s Hospital of Chengdu, Chengdu, 610021, People’s Republic of China

    Rui He

  3. Department of Joint Surgery, Sichuan Province Orthopedic Hospital, Chengdu, 610045, People’s Republic of China

    Peng Zhang

  4. Sichuan Provincial Ba-Yi Rehabilitation Center (Si Chuan Provincial Rehabilitation Hospital), Chengdu City, 631000, Sichuan Province, People’s Republic of China

    Yue He

  5. Department of Spine Surgery, Chongqing Orthopedics Hospital of Traditional Chinese Medical, Chongqing, 400000, People’s Republic of China

    Yingqi Liu

  6. School of Pharmacy, Southwest Medical University, Luzhou, 646000, People’s Republic of China

    Ting Li

Authors
  1. Huarui Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rui He
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yue He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yingqi Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guoyou Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ting Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HS collected the data, wrote the first and final manuscript. GW designed the study. RH, PZ and YL collected the data. TL and YH analyzed the data. All authors read and approved the final manuscript for publication.

Corresponding authors

Correspondence to Guoyou Wang or Ting Li.

Ethics declarations

Ethics approval and consent to participate

We obtained ethical approval for this study from the Medical and Health Research Ethics Committee in the affiliated traditional Chinese medical hospital of southwest medical university of Sichuan province, the second people’s hospital of Chengdu, Sichuan Province Orthopedic Hospital, Chongqing orthopedics hospital of traditional Chinese medical. The current study was carried out according to the Declaration of Helsinki. All the pertinent guidelines required by our institution for the preparation of retrospective studies have been followed. The data used in this study were anonymized before its use. A written informed consent to participate in the study was obtained from every participant.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Shen, H., He, R., Zhang, P. et al. Risk factors for postoperative medical morbidity and 3-month mortality in elderly patients with hip fracture following hip arthroplasty during COVID-19 pandemic. J Orthop Surg Res 18, 59 (2023). https://doi.org/10.1186/s13018-023-03511-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13018-023-03511-3

Keywords

  • Hip arthroplasty
  • COVID-19
  • Morality
  • Complications
  • Elderly patients

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X